Acute Graft Versus Host Disease - 162 Studies Found Status Study Completed Study Name: Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation Condition: Myelodysplastic Syndromes Leukemia, Myeloid, Acute Leukemi Date: 2014-04-15 Interventions: Radiation: Dynamic contrast-enhanced computed tomography Recruiting Study Name: A Phase II Trial of CD24Fc for Prevention of Acute Graft-versus-Host Disease Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplant Condition: Acute Myeloid Leukemia (AML) Chronic Myelogenous Leukemia (CML) Drug: CD24Fc Drug: Methotrexate Completed Study Name: Phase II Trial of Natalizumab (Tysabri®) Plus Prednisone for Initial Therapy of Acute Graft Versus Host Disease (aGVHD) of the Gastrointestinal Tract Condition: Graft Versus Host Disease Date: 2014-06-25 Interventions: Drug: Natalizumab Other Name: Completed Study Name: Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant Condition: Breast Cancer Chronic Myeloproliferative Disorders Gestati Date: 2006-12-11 Interventions: Biological: alemtuzumab Drug: methylpredni Completed Study Name: Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation Condition: Chronic Myeloproliferative Disorders Graft Versus Host Disease Drug: mycophenolate mofetil Drug: tacrolim Completed Study Name: Atorvastatin for the Prophylaxis of Acute Graft-versus-host Disease in Patients Undergoing Matched Sibling Allogeneic Transplantation Condition: Graft vs Host Disease Date: 2010-08-02 Interventions: Drug: Atorvastatin calcium (Lipitor) 40 mg PO daily Completed Study Name: Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant Condition: Cancer Date: 2006-07-26 Interventions: Drug: methotrexate Drug: methylprednisolon Active, not recruiting Study Name: Phase II Open Label Trial Of Tacrolimus/Methotrexate And Tocilizumab For The Prevention Of Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Condition: Hematopoietic Stem Cell Transplantation Date: 2014-07-30 Interventions: Drug: Tacrolimus Patients enro Completed Study Name: In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus With or Without Vidaza (Azacitidine) for Steroid-refractory Acute Graft-versus-host Disease Condition: Graft Versus Host Disease Date: 2011-10-13 Interventions: Drug: Cyclophospahmide and Sirolimus Completed Study Name: Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation Condition: Chronic Myeloproliferative Disorders Graft Versus Host Disease Drug: methotrexate Drug: sirolimus <<< Previous | Next >>>
